Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy

Ophthalmology

Volumn 109, Issue 10, 2002, Pages 1850-1854

  Char, Devron H ^a,c   Kroll, Stewart ^b   Phillips, Theodore L ^b   Quivey, Jeanne M ^b  

^a Tumori Foundation   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ANAMNESIS; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; FOLLOW UP; HELIUM ION RADIATION; HUMAN; MAJOR CLINICAL STUDY; PARTICLE RADIATION; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT FAILURE; UVEA MELANOMA;

BRACHYTHERAPY; FOLLOW-UP STUDIES; HELIUM; INCIDENCE; IODINE RADIOISOTOPES; MELANOMA; NEOPLASM RECURRENCE, LOCAL; PROTONS; RADIOTHERAPY, HIGH-ENERGY; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT FAILURE; UVEAL NEOPLASMS;

EID: 0036789485     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01174-0     Document Type: Article

References (35)

1. Moore RF. Choroidal sarcoma treated by intra-ocular insertion of radon seeds. Br J Ophthalmol 1930;14:145-52.
2. Stallard HB. Malignant melanoblastoma of the choroid. Bibl Ophthalmol 1968;75:16-38.
3. Sealy R, Buret A, Cleminshaw H, et al. Progress in the use of iodine therapy for tumours of the eye. Br J Radiol 1980;53: 1052-60.
4. Char DH, Castro JR, Kroll SM, et al. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990;108:209-14.
5. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-32.
6. Summanen P, Immonen I, Kivela T, et al. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol 1996;80:732-9.
7. 125I brachytherapy versus helium ion irradiation. Ophthalmology 1989;96:1708-15.
8. Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2000;238: 129-37.
9. Gragoudas ES. A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma. Trans Am Ophthalmol Soc 1998;96:691-720.
10. Gunduz K, Shields CL, Shields JA, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthamol 1999;127:579-89.
11. 60Co episcleral plaque therapy. Ophthalmology 1989;96:382-8.
12. Vrabec TR, Augsberger JJ, Gamel JW, et al. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991;98:984-8.
13. Duker JS, Augsburger JJ, Shields JA. Noncontiguous local recurrence of posterior uveal melanoma after cobalt 60 episcleral plaque therapy. Arch Ophthalmol 1989;107:1019-22.
14. Harbour JW, Char DH, Kroll S, et al. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology 1997;104:1785-92; discussion 1792-3.
15. Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand 1999; 77:414-7.
16. Char DH, Quivey JM, Castro JR, et al. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993;100:1547-54.
17. Gragoudas ES, Egan KM, Seddon JM, et al. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992;99:760-6.
18. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. New York: Springer-Verlag, 1992;287-317.
19. Ragde H, Korb LJ, Elgamal AA, et al. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 2000;89: 135-41.
20. Silva JJ, Tsang RW, Panzarella T, et al. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000:47:451-9.
21. Habrand JL, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 1999;44:255-63.
22. Summanen, P, Immomen I, Heikkonen J, et al. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg 1993;24:82-90.
23. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control. Cancer 1996;77:2356-62.
24. Char DH. Tumors of the Eye and Ocular Adnexa, 3rd ed. Lewiston, NY: BC Decker, 2001;416-30.
25. Williams DF, Mieler WF, Lewandowski M, Greenberg M. Echographic verification of radioactive plaque position in the treatment of melanomas. Arch Ophthalmol 1988;106:1623-4.
26. Harbour JW, Murray TG, Byme SF, et al. Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina 1996;16:129-34.
27. Abdel-Dayem HK, Trese MT. A technique for suturing peripapillary radioactive plaques. Am J Ophthalmol 1999;127: 224-6.
28. Clifton KH, Jirtle R. Mammary carcinoma cell population growth in preirradiated and unirradiated transplant sites. Viable tumor growth, vascularity, and the tumor-bed effect. Radiology 1975;117:459-65.
29. Camplejohn RS, Penhaligon M. The tumor bed effect: a cell kinetic and histological investigation of tumours growing in irradiated mouse skin. Br J Radiol 1985;58:443-51.
30. Michelson S, Leith J. Autocrine and paracrine growth factors in tumor growth: a mathematical model. Bull Math Biol 1991;53:639-56.
31. Milas L. Tumor bed effect in murine tumors: relationship to tumor take and tumor macrophage content. Radiat Res 1990; 123:232-6.
32. Leith JT, Michelson S. Tumor radiocurability: relationship to intrinsic tumor heterogeneity and to the tumor bed effect. Invasion Metastasis 1990;10:329-51.
33. O'Donoghue JA. Implications of nonuniform tumor doses for radioimmunotherapy. J Nucl Med 1999;40:1337-41.
34. Ito H, Barkley T Jr, Peters LJ, Milas L. Modification of tumor response to cyclophosphamide and irradiation by preirradiation of the tumor bed: prolonged growth delay but reduced curability. Int J Radiat Oncol Biol Phys 1985;11:547-53.
35. Leith JT, Padfield G, Quaranto L, Michelson S. Effect of pre-irradiation of transplantation site on growth characteristics and hypoxic fractions in human colon tumor xenografts. Cancer Res 1992;52:2162-6.